RAGE Biotech
PrivateLast Round
Series A
Nov 13, 2025
Total Funding Raised
$26.31M
Company Overview
RAGE Biotech is a biotechnology company developing novel therapeutics targeting the Receptor for Advanced Glycation End-products (RAGE) for patients with difficult-to-treat inflammatory disease.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RAGE Biotech Comps
Public and private peers based on sector, stage, and business model.
RAGE Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 13, 2025 | ||||
| Grant | Sep 4, 2024 | ||||
| Accelerator | Apr 18, 2024 | ||||
| Grant | Dec 21, 2022 | ||||
| Grant | Jul 20, 2022 | ||||
Grant | Jul 4, 2022 |
RAGE Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IP Group | Seed |
| Hostplus Superannuation Fund | Series A |
| IP Group Australia | Series A |
| mRNA Victoria | Grant |
| Monash Investment Holdings | Seed, Series A |
| Jumar Bioincubator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 13, 2025
$21M round completed.
RAGE Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RAGE Biotech's valuation, stock price, and market status.
